Finance
TD Cowen slashes price target on Cerevel Therapeutics Holdings Inc [CERE] – find out why.
Cerevel Therapeutics Holdings Inc [NASDAQ: CERE] loss -0.79% on the last trading session, reaching $42.93 price per share at the time. The company report on December 6, 2023 at 4:30 PM that AbbVie to Acquire Cerevel Therapeutics in Transformative Transaction to Strengthen Neuroscience Pipeline. Proposed
